Similarweb (NYSE:SMWB) Lowered to Hold Rating by Wall Street Zen

Similarweb (NYSE:SMWB) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday.

Several other brokerages also recently issued reports on SMWB. Oppenheimer reduced their price objective on Similarweb from $7.00 to $4.00 and set an “outperform” rating for the company in a research report on Thursday. Barclays set a $7.00 target price on Similarweb in a research note on Thursday. Citigroup reduced their price target on Similarweb from $11.00 to $8.50 and set a “buy” rating for the company in a research report on Friday. Weiss Ratings reissued a “sell (d-)” rating on shares of Similarweb in a research note on Monday, December 29th. Finally, Citizens Jmp lowered Similarweb from an “outperform” rating to a “market perform” rating in a report on Wednesday. Four equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $8.14.

Similarweb Stock Performance

Similarweb stock opened at $2.80 on Friday. Similarweb has a one year low of $2.22 and a one year high of $10.75. The company has a 50-day simple moving average of $5.86 and a 200-day simple moving average of $7.70. The firm has a market capitalization of $237.21 million, a P/E ratio of -7.17 and a beta of 1.09.

Similarweb (NYSE:SMWB) last posted its earnings results on Tuesday, February 17th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. Similarweb had a negative net margin of 11.65% and a negative return on equity of 70.38%. The firm had revenue of $72.76 million during the quarter, compared to analyst estimates of $76.45 million. As a group, sell-side analysts forecast that Similarweb will post -0.24 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. MQS Management LLC acquired a new stake in shares of Similarweb during the 2nd quarter valued at $125,000. Y Intercept Hong Kong Ltd raised its position in shares of Similarweb by 277.4% during the second quarter. Y Intercept Hong Kong Ltd now owns 117,831 shares of the company’s stock worth $924,000 after purchasing an additional 86,612 shares during the period. Migdal Insurance & Financial Holdings Ltd. raised its position in shares of Similarweb by 8.8% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 3,006,157 shares of the company’s stock worth $23,568,000 after purchasing an additional 243,600 shares during the period. ANTIPODES PARTNERS Ltd lifted its holdings in shares of Similarweb by 8.3% during the second quarter. ANTIPODES PARTNERS Ltd now owns 17,510 shares of the company’s stock valued at $137,000 after purchasing an additional 1,344 shares during the last quarter. Finally, Palogic Value Management L.P. lifted its holdings in shares of Similarweb by 12.4% during the second quarter. Palogic Value Management L.P. now owns 117,423 shares of the company’s stock valued at $921,000 after purchasing an additional 13,000 shares during the last quarter. 57.59% of the stock is owned by institutional investors and hedge funds.

Similarweb Company Profile

Similarweb Ltd. (NYSE: SMWB) is a digital intelligence company that provides insights into website and mobile app performance. Its cloud-based platform aggregates and analyzes data on global web traffic, user engagement, and referral sources, enabling businesses to benchmark their digital presence against competitors. The company’s core offering includes metrics on audience behavior, traffic acquisition channels, and industry trends, which are designed to inform strategic decisions in marketing, sales, and product development.

Similarweb’s platform delivers a suite of tools for market research, competitor analysis, and performance optimization.